Granulocyte - Macrophage colony-stimulating factor antagonizes the transforming growth factors-β-induced expression of FcγRIII (CD16) on human monocytes

Immunology

Volumn 87, Issue 1, 1996, Pages 162-167

  Kruger, M ^a,c   Coorevits, L ^a   De Wit, T P M ^b   Casteels Van Daele, M ^a   Van De Winkel, J G J ^b   Ceuppens, J L ^a,d  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF PRETORIA   (South Africa)

^d Laboratory of Experimental Psychology   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CYTOKINE; FC RECEPTOR; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; CELL DIFFERENTIATION; HUMAN; HUMAN CELL; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL;

BENZOQUINONES; BLOTTING, NORTHERN; CELL CULTURE TECHNIQUES; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; LACTAMS, MACROCYCLIC; MONOCYTES; PROTEIN-TYROSINE KINASES; QUINONES; RECEPTORS, IGG; RECOMBINANT PROTEINS; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030069195     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. GASSON J. (1991) Molecular physiology of granulocyte-macrophage colony-stimulating factor. Blood 77, 1131.
2. THOMPSON C.B., LINDSTEN T., LEDBETTER J.A. et al. (1989) CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines. Proc Natl Acad Sci USA 86, 1333.
3. MUNKER R., GASSON J., OGAWA M. & KOEFFLER H.P. (1986) Rccombinant human TNF induces production of granulocyte-macrophage colony-stimulating factor. Nature 323, 79.
4. BROUDY V.C., KAUSHANSKY K., HARLAN J.M. & ADAMSON J.W. (1987) Interleukin-1 stimulates human endothelial cells to produce granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor. J Immunol 139, 464.
5. WODNAR-FILIPOWICS A., HEUSSER C.H. & MORONI C. (1989) Production of the haemopoietic growth factors GM-CSF and interleukin-3 by mast cells in response to IgE receptor-mediated activation. Nature 339, 150.
6. GRANT S.M. & HEEL R.C. (1992) Recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF): A review of its pharmacological properties and prospective role in the management of myelosuppression. Drug 43, 516.
7. CLARKSON S.B & ORY P.A. (1988) CD16: developmentally regulated IgG Fc receptors on cultured human monocytes. J Exp Med 167, 408.
8. KINDT G.C., VAN DE WINKEL J.G.J., MOORE S.A. & ANDERSON C.L. (1991) Identification and structural characterization of Feγ-receptors on pulmonary alveolar macrophages. Am J Physiol 260, 403.
9. VAN DE WINKEL J.G.J. & ANDERSON C.L. (1991) Biology of human Fc receptors. J Leukoc Biol 49, 511.
10. RAVETCH J.V. & PERUSSIA B. (1989) Alternative membrane forms of FcRIII (CD16) on human NK cells and neutrophils: Cell-type specific expression of two genes which differ in single nucleotide substitution. J Exp Med 170, 481.
11. PASSLIC B., FLIEGER D. & ZIEGLER-HETTBROCK H.W.L. (1989) Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 74, 2527.
12. WELCH G.R., WONG, H.L. & WAHL S.M. (1990) Selective induction of FcγRIII on human monocytes by transforming growth factor-β. J Immunol 144, 3444.
13. CONNOR R.I., SHEN L. & FANGER M.W. (1990) Evaluation of the antibody-dependent cytotoxic capabilities of individual human monocytes. J Immunol 145, 1483.
14. VAN SCHIE R.C.A.A., VERSTRATEN R.G.G., VAN DE WINKEL J.G.J., TAX W.J.M. & MULDER P.H.M. (1992) Effect of recombinant IFN-γ (rIFN-γ) on the mechanism of human macrophage IgG FcRI-mediated cytotoxicity. J Immunol 148, 169.
15. PERUSSIA B. & TRINCHIERI G. (1984) Antibody 3G8 specific for the human neutrophil Fc receptor reacts with natural killer cells. J Immunol 132, 1410.
16. PERUSSIA B., TRINCHIERI G., JACKSON A. et al. (1984) The Fc receptor for IgG on human natural killer cells: phenotypic, functional and comparative studies with monoclonal antibodies. J Immunol 133, 180.
17. ALDERSON M.R., TOUGH T.W., ZIEGLER S.F. & ARMITAGE R.J. (1992) Regulation of human monocyte cell-surface and soluble CD23 (Fc-εRH) by granulocyle-macrophage colony-stimulating factor and IL-3. J Immunol 149, 1252.
18. ROSSMAN M.D., RUIZ P., COMBER P., GOMEZ P., ROTTEM M. & SCHREIBER A.D. (1993) Modulation of macrophage Fcγ receptors by rGM-CSF. Exp Hemat 21, 177.
19. WONG H.L., WELCH G.R., BRANDES M.E. & WAHL S.M. (1991) IL-4 antagonizes induction of FcγRIII(CD16) expression by transforming growth factor-β on human monocytes. J Immunol 147, 1843.
20. MIYAJIMA A., KITAMURA T., HARADA N., YOKOTA T. & ARAI K. (1992) Cytokine receptors and signal transduction. Annu Rev Immunol 10, 295.
21. HANAZO Y., CHIBA S., SASAKI K. et al. (1993) c-fps/fes protein-tyrosine kinase is implicated in a signalling pathway triggered by granulocyte-macrophage colony-stimulating factor and interleukin-3. EMBO J 12, 1641.
22. MALEFYT R. DE W., FIGDOR C.G. & DE VRIES J.E. (1993) Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. J Immunol 151, 6370.
23. BORDER W.A. & ROUSLAHTI E. (1992) Transforming growth factor-in disease: The dark side of tissue repair. J Clin Invest 90, 1.
24. NELSON B.J., RALPH P., GREEN S.J. & NACY C.A. (1991) Differential susceptibility of activated macrophage cytotoxic effector reactions to the suppressive effects of transforming growth factor-β. J Immunol 146, 1849.
25. NOBLE P.W., HENSON P.M., LUCAS C., MORA-WORMS M., CARRÉ P.C. & RICHES D.W.H. (1993) Transforming growth factor-β primes macrophages to express inflammatory gene products in response to particulate stimuli by an autocrine/paracrine mechanism. J Immunol 151, 979.
26. CLARKSON S.B., KIMBERLY R.P., VALINSKY J.E. et al. (1986) Blockade of clearance of immune complexes by an anti-Fcγ receptor monoclonal antibody. J Exp Med 164, 474.
27. CLARKSON S.B., BUSSEL J.B., KIMBERLY R.P., VALINSKY J.E., NACHMAN R.L. & UNKELESS J.C. (1986) Treatment of refractory immune thrombocytopenic purpura with an anti-Fcγ-receptor antibody. N Engl J Med 314, 1236.
28. ANDERSON C.L., SHEN L., EICHER D.M., WEWERS M.D. & GILL J.K. (1990) Phagocytosis mediated by three distinct Fcγ-receptor classes in human leucocytes. J Exp Med 171, 1333.
29. TREZZINI C., JUNGI T.W., SPYCHER M.O., MALY F.E. & RAO P. (1990) Human monocytes CD36 and CD16 are signaling molecules. Immunology 71, 29.
30. TURNER M., CHANTRY D., KATSIKIS P., BERGER A., BRENNAN F.M. & FELDMANN M. (1991) Induction of the interleukin-1 receptor antagonist protein by transforming growth factor-β Eur J Immunol 21, 1635.
31. CZARNIECKI C.W., CHUI H.H., WONG G.H.W., MCCABE S.M. & PALLADINO M.A. (1988) Transforming growth factor-β1 modulates the expression of class II histocompatibility antigens on human cells. J Immunol 140, 4217.
32. ALLEN J.B., WONG H.L., GUYRE P.M., SIMON G.L. & WAHL S.M. (1991) Association of circulating receptor FcγRIII-positive mono. cytes in AIDS patients with elevated levels of transforming growth factor-β. J Clin Invest 87, 1773.
33. WAHL S.M., ALLEN J.B., WELCH G.R. & WONG H.L. (1992) Transforming growth factor-β in synovial fluids modulates FcγRIII (CD16) expression on mononuclear phagocytes. J Immunol 148, 485.
34. SMITH P.D., LAMERSON C.L., WONG H.L., WAHL L.M. & WAHL S.M. (1990) Granulocyte-macrophage colony-stimulating factor stimulates human monocyte accessory cell function. J Immunol 144, 3829.
35. YOUNG D.A., LOWE L.D. & CLARK S.C. (1990) Comparison of the effects of IL-3, granulocyte-macrophage colony-stimulating factor, and macrophage colony-stimulating factor in supporting monocyte differentiation in culture. J Immunol 145, 607.
36. HAMILTON J.A. (1993) Colony-stimulating factors, cytokines and monocyte-macrophages some controversies. Immunol Today 14, 18.
37. FISCHER H.G., FROSCH S., RESKE K. & RESKE-KUNZ A.B. (1988) Granulocyte-macrophage colony-stimulating factor activates macrophages derived from bone marrow cultures to synthesis of MHC class II molecules and to augment antigen presentation function. J Immunol 141, 3882.